Hunter Gillies insider trades: Aerovate Therapeutics (AVTE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Hunter reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 13, 2024 | AVTE | ↓ Sell | 6,000 | $24.50 | $147K | Direct | Jun 14, 2024 (1d) |
| May 17, 2024 | AVTE | ↓ Sell | 4,000 | $21.08 | $84K | Direct | May 17, 2024 (0d) |
| Apr 17, 2024 | AVTE | ↓ Sell | 4,000 | $22.38 | $90K | Direct | Apr 19, 2024 (2d) |
| Mar 28, 2024 | AVTE | ↓ Sell | 9,000 | $29.50 | $266K | Direct | Apr 1, 2024 (4d) |
| Mar 18, 2024 | AVTE | ↓ Sell | 7,000 | $25.87 | $181K | Direct | Mar 20, 2024 (2d) |
| Mar 7, 2024 | AVTE | ↓ Sell | 8,975 | $24.50 | $220K | Direct | Mar 11, 2024 (4d) |
| Feb 23, 2024 | AVTE | ↓ Sell | 511 | $19.50 | $10K | Direct | Feb 27, 2024 (4d) |
| Feb 20, 2024 | AVTE | ↓ Sell | 3,489 | $20.23 | $71K | Direct | Feb 22, 2024 (2d) |
| Jan 17, 2024 | AVTE | ↓ Sell | 4,000 | $19.50 | $78K | Direct | Jan 19, 2024 (2d) |
| Dec 27, 2023 | AVTE | ↓ Sell | 125 | $24.50 | $3K | Direct | Dec 29, 2023 (2d) |
| Dec 20, 2023 | AVTE | ↓ Sell | 4,000 | $19.50 | $78K | Direct | Dec 22, 2023 (2d) |
| Dec 14, 2023 | AVTE | ↓ Sell | 12,000 | $19.50 | $234K | Direct | Dec 15, 2023 (1d) |
| May 19, 2023 | AVTE | ↓ Sell | 65 | $19.50 | $1K | Direct | May 23, 2023 (4d) |
| May 17, 2023 | AVTE | ↓ Sell | 1,090 | $19.59 | $21K | Direct | May 19, 2023 (2d) |
| Apr 21, 2023 | AVTE | ↓ Sell | 4,000 | $19.50 | $78K | Direct | Apr 25, 2023 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Hunter Gillies's insider trades
Hunter Gillies is Chief Medical Officer at Aerovate Therapeutics (AVTE). Since Apr 21, 2023, Hunter has reported no open-market purchases and 15 sales worth $1.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (15 filings), grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVTE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.